Keyphrases
Lupus
100%
Treatment Pathways
100%
Corticosteroids
100%
Systemic Lupus Erythematosus
33%
SLE Disease Activity Index (SLEDAI)
25%
American College of Rheumatology
16%
Cumulative Dose
16%
Systemic Lupus Erythematosus Patient
16%
New Onset
16%
Descriptive Statistics
8%
Well-defined
8%
Patient Demographics
8%
Mixed Models
8%
Rheumatic Diseases
8%
Damage Index
8%
Inception Cohort
8%
Systemic Lupus International Collaborating Clinics
8%
High Disease Activity
8%
Disease Activity Score
8%
Disease Duration
8%
Treatment Algorithm
8%
Daily Dose
8%
Classification Criteria
8%
Treatment Patterns
8%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
100%
Immunosuppressant
66%
Antimalarial Agent
66%
SLEDAI
50%
Rheumatology
33%
Disease
16%
Drug Therapy
16%
Mixed Model
16%
Rheumatic Disease
16%
Disease Activity
16%
Disease Activity Score
16%
Disease Duration
16%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
100%
Immunosuppressive Agent
44%
Disease Activity
44%
Antimalarial Agent
44%
Disease
11%
Rheumatic Disease
11%
Mixed Model
11%
Disease Duration
11%
Disease Activity Score
11%
Neuroscience
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
100%
Antimalarial Agent
44%
Rheumatology
22%
Immunology and Microbiology
Lupus Erythematosus
100%
Systemic Lupus Erythematosus
100%
Antimalarial Agent
44%
Rheumatic Disease
11%
Psychology
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
100%
Mixed Model
14%
Rheumatic Disorder
14%